Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

OmniGene Inc (AKA: OmniGene Bioproducts Inc)
Profile last edited on: 3/15/17      CAGE:       UEI:

Business Identifier: NO Business Identifier is currently available for this company.
Year Founded
1985
First Award
1988
Latest Award
1995
Program Status
Inactive (Acquired)
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

763 D Concord Avenue
Cambridge, MA 02138
Location: Single
Congr. District: 05
County: Middlesex

Public Profile

In July 2008, OmniGene Inc was acquired by BioEnergy International, LLC. mniGene Bioproducts, Inc. acquired the operating bioproducts division of OmniGene, Inc The acquiring firm does research based on the manipulation of DNA: cloning, engineering and expressing genes. Product development is directed into bioproducts. The bioproduct group has developed proprietary microbial expression systems in 4 host organisms for the production of specialty enzymes, nutritional supplements and food additives.

Extent of SBIR involvement

User Avatar
Phase I Awards
4
Phase II Awards
1
Conversion Rate
25.00%
Phase I Dollars
$298,564
Phase II Dollars
$850,000
Total Awarded
$1,148,564

Synopsis: Awardee Business Condition

Employee Range
10-14
Revenue Range
1M-1.5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
5-9

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
1995 1 NIH $199,801
Project Title: DNA Probes for Gram Positive Periodontal Pathogens
1995 1 NIH $99,963
Project Title: In-Office Assay for Periodontitis Associated Bacteria
1994 2 NIH $800,000
Project Title: DNA probes for the detection of periodontal pathogens
1992 1 NIH $48,800
Project Title: DNA probe amplification for detecting oral bacteria

Key People / Management

  Janice Pero -- Former President and CEO

  Keith Backman

  Peter Mahler -- Vice-President

  Scott Van Arsdell -- Vice President, Immunoassay Technology

Company News

There are no news available.